Variant report

Variant	nsv1064416
Chromosome Location	chr16:32080861-32485187
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:2825)
CpG islands
(count:3299)
Chromatin interactive
region (count:0)
LncRNA
region (count:21)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:2825 , 50 per page) page: 1 2 3 4 5 6 7 ... 57

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr16:32345726-32345816	HepG2	liver:	n/a	n/a
2	ARID3A	chr16:32131861-32132041	HepG2	liver:	n/a	n/a
3	ARID3A	chr16:32295698-32295892	HepG2	liver:	n/a	n/a
4	ATF1	chr16:32194699-32194908	K562	blood:	n/a	n/a
5	ATF1	chr16:32363593-32363793	K562	blood:	n/a	n/a
6	BATF	chr16:32094016-32094261	GM12878	blood:	n/a	chr16:32094090-32094099
7	BATF	chr16:32102790-32103063	GM12878	blood:	n/a	n/a
8	BATF	chr16:32148154-32148425	GM12878	blood:	n/a	n/a
9	BATF	chr16:32333643-32333817	GM12878	blood:	n/a	n/a
10	BATF	chr16:32366962-32367454	GM12878	blood:	n/a	chr16:32367243-32367254
11	BATF	chr16:32101215-32101624	GM12878	blood:	n/a	chr16:32101437-32101448
12	BATF	chr16:32373029-32373235	GM12878	blood:	n/a	n/a
13	BATF	chr16:32099142-32100510	GM12878	blood:	n/a	n/a
14	BATF	chr16:32144482-32144672	GM12878	blood:	n/a	n/a
15	BATF	chr16:32140974-32141195	GM12878	blood:	n/a	n/a
16	BATF	chr16:32435147-32435451	GM12878	blood:	n/a	n/a
17	BATF	chr16:32139079-32139319	GM12878	blood:	n/a	n/a
18	BATF	chr16:32451259-32451478	GM12878	blood:	n/a	n/a
19	BATF	chr16:32335083-32335294	GM12878	blood:	n/a	n/a
20	BATF	chr16:32108268-32108476	GM12878	blood:	n/a	n/a
21	BATF	chr16:32105349-32105637	GM12878	blood:	n/a	n/a
22	BATF	chr16:32108354-32108543	GM12878	blood:	n/a	n/a
23	BATF	chr16:32102770-32103216	GM12878	blood:	n/a	n/a
24	BATF	chr16:32100565-32100763	GM12878	blood:	n/a	n/a
25	BATF	chr16:32098574-32098849	GM12878	blood:	n/a	n/a
26	BATF	chr16:32368414-32368848	GM12878	blood:	n/a	n/a
27	BATF	chr16:32133941-32134130	GM12878	blood:	n/a	n/a
28	BATF	chr16:32368458-32368823	GM12878	blood:	n/a	n/a
29	BATF	chr16:32150053-32150293	GM12878	blood:	n/a	n/a
30	BATF	chr16:32144456-32144674	GM12878	blood:	n/a	n/a
31	BATF	chr16:32133244-32133444	GM12878	blood:	n/a	n/a
32	BATF	chr16:32099023-32099501	GM12878	blood:	n/a	n/a
33	BATF	chr16:32335047-32335307	GM12878	blood:	n/a	n/a
34	BATF	chr16:32099644-32100206	GM12878	blood:	n/a	n/a
35	BATF	chr16:32101090-32101595	GM12878	blood:	n/a	chr16:32101437-32101448
36	BATF	chr16:32361068-32361342	GM12878	blood:	n/a	n/a
37	BCL11A	chr16:32100955-32101646	GM12878	blood:	n/a	n/a
38	BCL11A	chr16:32297425-32297655	GM12878	blood:	n/a	n/a
39	BCL11A	chr16:32106782-32107034	GM12878	blood:	n/a	n/a
40	BCL11A	chr16:32368461-32368854	GM12878	blood:	n/a	n/a
41	BCL11A	chr16:32118418-32118587	GM12878	blood:	n/a	n/a
42	BCL11A	chr16:32369671-32369887	GM12878	blood:	n/a	n/a
43	BCL11A	chr16:32108319-32108554	GM12878	blood:	n/a	n/a
44	BCL11A	chr16:32105229-32105525	GM12878	blood:	n/a	n/a
45	BCL11A	chr16:32229562-32229735	GM12878	blood:	n/a	n/a
46	BCL11A	chr16:32098612-32098854	GM12878	blood:	n/a	n/a
47	BCL11A	chr16:32363877-32364075	GM12878	blood:	n/a	n/a
48	BCL11A	chr16:32108342-32108553	GM12878	blood:	n/a	n/a
49	BCL11A	chr16:32099052-32099504	GM12878	blood:	n/a	n/a
50	BCL11A	chr16:32361062-32361240	GM12878	blood:	n/a	n/a

(count:3299 , 50 per page) page: 1 2 3 4 5 6 7 ... 66

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr16:32095405-32095455	Hepatocyte	liver:	n/a
2	chr16:32254800-32254850	HEK293	kidney:	embryo
3	chr16:32330302-32330352	SAEC	small airway:	n/a
4	chr16:32213913-32213963	HAEpiC	amniotic membrane:	n/a
5	chr16:32289757-32289807	HCM	heart:	n/a
6	chr16:32095405-32095455	Hepatocyte	liver:	n/a
7	chr16:32254800-32254850	HEK293	kidney:	embryo
8	chr16:32330302-32330352	SAEC	small airway:	n/a
9	chr16:32213913-32213963	HAEpiC	amniotic membrane:	n/a
10	chr16:32289757-32289807	HCM	heart:	n/a
11	chr16:32165153-32165203	AG10803	skin:	n/a
12	chr16:32096464-32096514	HepG2	liver:	n/a
13	chr16:32212399-32212449	AG09319	gingival:	n/a
14	chr16:32323497-32323547	HAEpiC	amniotic membrane:	n/a
15	chr16:32322028-32322078	PFSK-1	brain:	n/a
16	chr16:32360338-32360388	HUVEC	blood vessel:	n/a
17	chr16:32323497-32323547	T-47D	breast:	n/a
18	chr16:32359536-32359586	RPTEC	kidney:	n/a
19	chr16:32276952-32277002	Hepatocyte	liver:	n/a
20	chr16:32178973-32179023	Hela-S3	cervix:	n/a
21	chr16:32360338-32360388	HAEpiC	amniotic membrane:	n/a
22	chr16:32363978-32364028	Hela-S3	cervix:	n/a
23	chr16:32355981-32356031	HEEpiC	esophagus:	n/a
24	chr16:32123983-32124033	RPTEC	kidney:	n/a
25	chr16:32323497-32323547	HIPEpiC	eye:	n/a
26	chr16:32362057-32362107	Hela-S3	cervix:	n/a
27	chr16:32130303-32130353	NB4	blood:	n/a
28	chr16:32123983-32124033	SK-N-MC	brain:	n/a
29	chr16:32360419-32360469	HMEC	breast:	n/a
30	chr16:32265041-32265091	AG09309	skin:	n/a
31	chr16:32289928-32289978	SK-N-SH_RA	brain:	n/a
32	chr16:32359536-32359586	LNCaP	prostate:	n/a
33	chr16:32214185-32214235	MCF-7	breast:	n/a
34	chr16:32213944-32213994	IMR90	lung:	fetal
35	chr16:32213944-32213994	HCM	heart:	n/a
36	chr16:32097291-32097341	BJ	skin:	n/a
37	chr16:32323497-32323547	GM06990	blood:	n/a
38	chr16:32359756-32359806	SAEC	small airway:	n/a
39	chr16:32322028-32322078	T-47D	breast:	n/a
40	chr16:32252787-32252837	HAEpiC	amniotic membrane:	n/a
41	chr16:32322028-32322078	ECC-1	luminal epithelium:	n/a
42	chr16:32212399-32212449	HL-60	blood:	n/a
43	chr16:32276952-32277002	ECC-1	luminal epithelium:	n/a
44	chr16:32359673-32359723	AG10803	skin:	n/a
45	chr16:32289928-32289978	HMEC	breast:	n/a
46	chr16:32360428-32360478	AG04449	skin:	fetal
47	chr16:32264389-32264439	U87	brain:	n/a
48	chr16:32255825-32255875	HAEpiC	amniotic membrane:	n/a
49	chr16:32360419-32360469	GM19239	blood:	n/a
50	chr16:32321943-32321993	AG04449	skin:	fetal

No data

(count:21 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AC133485.1.1-7	chr16:32200583-32200802	NONHSAT141994
2	lnc-TP53TG3-4	chr16:32274229-32274612	ENSG00000260402.1
3	lnc-AC133485.1.1-8	chr16:32443002-32443139	NONHSAT142015
4	lnc-TP53TG3-7	chr16:32261941-32262132	ENSG00000260575.1
5	lnc-TP53TG3-16	chr16:32450390-32451887	NONHSAT142016
6	lnc-AC133485.1.1-1	chr16:32199654-32199738	ENSG00000260847.1
7	lnc-AC133485.1.1-8	chr16:32442004-32442108	NONHSAT142015
8	lnc-AC133485.1.1-8	chr16:32447309-32447521	NONHSAT142015
9	lnc-TP53TG3-4	chr16:32275068-32275108	ENSG00000260402.1
10	lnc-AC133485.1.1-8	chr16:32402131-32402273	NONHSAT142015
11	lnc-TP53TG3-16	chr16:32452294-32452480	NONHSAT142016
12	lnc-TP53TG3-3	chr16:32335100-32335382	XLOC_011921
13	lnc-AC133485.1.1-1	chr16:32204071-32204851	ENSG00000260847.1
14	lnc-TP53TG3-7	chr16:32265674-32265743	ENSG00000260575.1
15	lnc-AC133485.1.1-8	chr16:32399456-32399634	NONHSAT142015
16	lnc-AC133485.1.1-8	chr16:32416298-32416473	NONHSAT142015
17	lnc-TP53TG3-2	chr16:32465933-32470079	ENSG00000261541.1
18	lnc-TP53TG3-3	chr16:32334099-32334218	XLOC_011921
19	lnc-AC133485.1.1-8	chr16:32438035-32438184	NONHSAT142015
20	lnc-AC133485.1.1-8	chr16:32437097-32437203	NONHSAT142015
21	lnc-AC133485.1.1-8	chr16:32403379-32403556	NONHSAT142015

No data

Variant related genes	Relation type
ENSG00000260540	TF binding region
ENSG00000261541	TF binding region
ENSG00000260402	TF binding region
ENSG00000260662	TF binding region
ENSG00000260575	TF binding region
ENSG00000259822	TF binding region
HERC2P4	TF binding region
ENSG00000260344	TF binding region
TP53TG3D	TF binding region
ENSG00000260584	TF binding region
ENSG00000261127	TF binding region
ENSG00000260649	TF binding region
ACTR3BP3	TF binding region
ENSG00000260847	TF binding region
ENSG00000261727	TF binding region
ENSG00000260866	TF binding region
PABPC1P13	TF binding region
ENSG00000260516	TF binding region
ENSG00000260540	CpG island
ENSG00000261541	CpG island
ENSG00000260402	CpG island
ENSG00000260662	CpG island
ENSG00000260575	CpG island
ENSG00000259822	CpG island
HERC2P4	CpG island
ENSG00000260344	CpG island
TP53TG3D	CpG island
ENSG00000260584	CpG island
ENSG00000261127	CpG island
ENSG00000260649	CpG island
ACTR3BP3	CpG island
ENSG00000260847	CpG island
ENSG00000261727	CpG island
ENSG00000260866	CpG island
PABPC1P13	CpG island
ENSG00000260516	CpG island
LBR	miRNA target sites

Extended variants
information (count: 4187 )
Associated
traits (count: 133 )

Variant overlapped rSNPs/rCNVs (count:4187 , 50 per page) page: 1 2 3 4 5 6 7 ... 84

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs201548592	chr16:32095200-32095201	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs576798189	chr16:32095231-32095232	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs377661070	chr16:32095236-32095237	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs371703116	chr16:32095249-32095250	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs374855381	chr16:32095266-32095267	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs370857727	chr16:32095279-32095280	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs374473440	chr16:32095284-32095285	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs377723452	chr16:32095310-32095311	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs370318934	chr16:32095311-32095312	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs374255453	chr16:32095320-32095321	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs562260682	chr16:32095330-32095331	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs199538695	chr16:32095332-32095333	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs200784446	chr16:32095336-32095337	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs529472647	chr16:32095342-32095343	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs547835243	chr16:32095350-32095351	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs559441160	chr16:32095352-32095353	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs201773621	chr16:32095353-32095354	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs79028972	chr16:32095366-32095367	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs80341709	chr16:32095380-32095381	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs368358007	chr16:32095411-32095412	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs533286564	chr16:32095413-32095414	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs551354476	chr16:32095428-32095429	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs142104648	chr16:32095444-32095445	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs375547058	chr16:32095446-32095447	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs538097778	chr16:32095448-32095449	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs368588892	chr16:32095456-32095457	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs549819485	chr16:32095457-32095458	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs184603646	chr16:32095472-32095473	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs188694619	chr16:32095474-32095475	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs192810533	chr16:32095480-32095481	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs535313938	chr16:32095508-32095509	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs113317362	chr16:32095511-32095512	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs554040322	chr16:32095529-32095530	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs112558489	chr16:32095552-32095553	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs373383745	chr16:32095559-32095560	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs201997996	chr16:32095570-32095571	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs138978511	chr16:32095587-32095588	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs144747297	chr16:32095596-32095597	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs140183171	chr16:32095618-32095619	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs572153482	chr16:32095627-32095628	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs369733467	chr16:32095637-32095638	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs62041288	chr16:32095652-32095653	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs200811855	chr16:32095664-32095665	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs374113197	chr16:32095671-32095672	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs377752665	chr16:32095685-32095686	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs62041289	chr16:32095686-32095687	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs557781361	chr16:32095704-32095705	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs62041290	chr16:32095707-32095708	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs377016746	chr16:32095713-32095714	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs370078440	chr16:32095716-32095717	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:133)

Disease	PMID	Source
Hodgkin''s lymphoma	20651079	CNVD
Metanephric adenoma	20802469	CNVD
Melanoma	18172304	CNVD
Breast cancer	16608533	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Lung adenocarcinoma	17086460	CNVD
Lung cancer	17086460	CNVD
Autism	22566537	CNVD
Intellectual disability	22566537	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Ductal carcinoma	22052326	CNVD
Breast cancer	21509527	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	21858162	CNVD
Hepatocellular carcinoma	16750200	CNVD
Mental retardation	19951919	CNVD
Colorectal cancer	16272173	CNVD
Bladder cancer	21909424	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21785460	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	21990379	CNVD
Astrocytoma	22246337	CNVD
Myelofibrosis	22110671	CNVD
Epilepsy	22499536	CNVD
Attention deficit hyperactivity disorder	21324949	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22513405	CNVD
Autism	22958593	CNVD
Autism	18184952	CNVD
Autism	19966786	CNVD
Autism	21394203	CNVD
Autism	21969575	CNVD
Autism	22241247	CNVD
Autism	20970697	CNVD
Autism	20942916	CNVD
Epilepsy	20970697	CNVD
Intellectual disability	22045946	CNVD
Mental retardation	19966786	CNVD
Developmental delay	20808231	CNVD
Obesity	20808231	CNVD
Autism	18923514	CNVD
Obesity	21881559	CNVD
Obesity	21956041	CNVD
Autism	20659124	CNVD
Mental retardation	21062444	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	21285140	CNVD
Schizophrenia	22885689	CNVD
Schizophrenia	20553308	CNVD
Schizophrenia	20970697	CNVD
Schizophrenia	20433910	CNVD
Schizophrenia	22241247	CNVD
Autism	19242545	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Intracranial ependymoma	16609018	CNVD
Schizophrenia	21399695	CNVD
Autism	21956041	CNVD
Disorders of sex development	21048976	CNVD
Autism	22067053	CNVD
Autism	18156158	CNVD
Mental retardation	20152051	CNVD
Autism	19218893	CNVD
Autism	21289514	CNVD
Schizophrenia	19855392	CNVD
neurodevelopmental Syndrome	20503337	CNVD
Benign familial neonatal-infantile seizures	21060786	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Cancer	21183584	CNVD
Low-grade fibromyxoid sarcoma	21536545	CNVD
Breast cancer	21045282	CNVD
Neuroblastoma	20406844	CNVD
Autism	19050728	CNVD
Epilepsy	20923578	CNVD
Psychiatric disorder	19050728	CNVD
Schizophrenia	19348701	CNVD
Attention deficit hyperactivity disorder	19097825	CNVD
Autism	20964600	CNVD
Schizophrenia	19955444	CNVD
Schizophrenia	18990708	CNVD
Schizophrenia	19571808	CNVD
Breast cancer	20409316	CNVD
Severe combined immunodeficiency	19097825	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Autism	18522746	CNVD
Sezary syndrome	18413736	CNVD
Wilms tumour	21544195	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Cancer	20164920	CNVD
Autism	19287141	CNVD
early-passage human iPS cells	21368824	CNVD
Schizophrenia	20967226	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
Breast cancer	17142309	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	22297974	CNVD
Recurrent pregnancy loss	19789632	CNVD

Chromatin state (count:340 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:32095200-32095400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
2	chr16:32095400-32096400	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
3	chr16:32096000-32096200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
4	chr16:32096000-32096200	Active TSS	Primary T regulatory cells fromperipheralblood	blood
5	chr16:32096200-32096400	Flanking Bivalent TSS/Enh	Primary B cells from peripheral blood	blood
6	chr16:32096200-32096400	Flanking Bivalent TSS/Enh	Primary T regulatory cells fromperipheralblood	blood
7	chr16:32096200-32096400	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland
8	chr16:32096200-32096600	Flanking Bivalent TSS/Enh	Placenta	Placenta
9	chr16:32096200-32096800	Active TSS	Primary T helper cells fromperipheralblood	blood
10	chr16:32096200-32096800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
11	chr16:32096200-32097000	Bivalent/Poised TSS	Primary T helper cells PMA-I stimulated	--
12	chr16:32096200-32097200	Active TSS	Primary T cells from cord blood	blood
13	chr16:32096200-32097200	Flanking Bivalent TSS/Enh	Primary T cells fromperipheralblood	blood
14	chr16:32096200-32097200	Active TSS	Primary T helper naive cells fromperipheralblood	blood
15	chr16:32096200-32097200	Active TSS	Foreskin Melanocyte Primary Cells skin01	Skin
16	chr16:32096200-32097200	Active TSS	Primary mononuclear cells fromperipheralblood	Blood
17	chr16:32096200-32097400	Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
18	chr16:32096200-32097400	Active TSS	Right Atrium	heart
19	chr16:32096200-32097400	Bivalent/Poised TSS	A549	lung
20	chr16:32096200-32097400	Active TSS	Osteobl	bone
21	chr16:32096400-32096600	Flanking Bivalent TSS/Enh	Primary monocytes fromperipheralblood	blood
22	chr16:32096400-32096600	Flanking Bivalent TSS/Enh	Primary Natural Killer cells fromperipheralblood	blood
23	chr16:32096400-32096600	Bivalent/Poised TSS	Duodenum Smooth Muscle	Duodenum
24	chr16:32096400-32096800	Bivalent/Poised TSS	Primary B cells from peripheral blood	blood
25	chr16:32096400-32096800	ZNF genes & repeats	Primary hematopoietic stem cells short term culture	blood
26	chr16:32096400-32096800	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
27	chr16:32096400-32096800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
28	chr16:32096400-32096800	ZNF genes & repeats	Right Ventricle	heart
29	chr16:32096400-32096800	Active TSS	HSMM	muscle
30	chr16:32096400-32097000	Bivalent Enhancer	Fetal Muscle Leg	muscle
31	chr16:32096400-32097200	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
32	chr16:32096400-32097200	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin01	Skin
33	chr16:32096400-32097200	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
34	chr16:32096400-32097200	Active TSS	Rectal Smooth Muscle	rectum
35	chr16:32096400-32097400	Bivalent/Poised TSS	Primary T regulatory cells fromperipheralblood	blood
36	chr16:32096400-32097600	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
37	chr16:32096600-32096800	Bivalent Enhancer	Placenta	Placenta
38	chr16:32096600-32097000	Bivalent/Poised TSS	Primary monocytes fromperipheralblood	blood
39	chr16:32096600-32097000	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
40	chr16:32096600-32097200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
41	chr16:32096800-32097000	Flanking Bivalent TSS/Enh	Primary T helper cells fromperipheralblood	blood
42	chr16:32096800-32097000	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin
43	chr16:32096800-32097000	Bivalent Enhancer	Dnd41	blood
44	chr16:32096800-32097200	Flanking Bivalent TSS/Enh	Primary B cells from peripheral blood	blood
45	chr16:32096800-32097200	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Female	--
46	chr16:32096800-32097200	Bivalent/Poised TSS	Cortex derived primary cultured neurospheres	brain
47	chr16:32096800-32097200	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
48	chr16:32096800-32097200	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland
49	chr16:32096800-32097200	Flanking Bivalent TSS/Enh	Placenta	Placenta
50	chr16:32096800-32097200	Active TSS	Ovary	ovary

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links